apxt505
Edited
In an otherwise dismal day in the markets, people seem to be waking up to the long play I have mentioned in the new weight loss drug sector. Today has seen significant gains for manufacturer Eli LIlly $LLY (Eli Lilly & Co) , drug delivery technology supplier Stevenato $STVN (Stevanato Group S.p.A.) and Gerresheimer $GXI.DE (Gerresheimer) but above all there is a recovery in the share price of Weight Watchers $WW (Weight Watchers International Inc.) (my largest single equity position). As I noted last week, having massive pent up demand you cannot yet meet is a high class problem for Weight Watchers. $NOVO-B.CO (Novo Nordisk B A/S) is also doing very well – but is very expensive. All in all a positive development for the portfolio while macro factors (which I described in a post earlier today) pull down the market generally. This is not investment advice. You must do your own research before investing in any equities mentioned here. Whole portfolio +17.65% ytd www.etoro.com/people/apxt505/portfolio